The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? [version 1; peer review: 3 approved]

Cited by papers we hold 4

• The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy · 2025
  No notice
• The role of BCL-2 family proteins in regulating apoptosis and cancer therapy · 2022
  No notice
• Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling · 2022
  No notice
• Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.